- Conditions
- Head and Neck Neoplasms, Metastatic Salivary Gland Carcinoma, Mouth Diseases, +10 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- Kaiser Permanente Dublin Dublin, California, United States
- Kaiser Permanente-Fremont Fremont, California, United States
Clinical trial condition
Recurrent Salivary Gland Carcinoma
Explore clinical trials studying Recurrent Salivary Gland Carcinoma. Study availability and eligibility vary by location and protocol.
13 public trials
1 recruiting study
Recurrent Salivary Gland Carcinoma trial results
NCT00954226
- Conditions
- Head and Neck Neoplasms, Mouth Diseases, Mouth Neoplasms, +9 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT02538510
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +32 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT01175980
- Conditions
- Head and Neck Neoplasms, Mouth Diseases, Mouth Neoplasms, +19 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- City of Hope South Pasadena South Pasadena, California, United States
- Yale University New Haven, Connecticut, United States
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT01254617
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Colonic Diseases, +66 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
NCT01604772
- Conditions
- Head and Neck Neoplasms, Mouth Diseases, Mouth Neoplasms, +14 more
- Locations
-
- Beebe Medical Center Lewes, Delaware, United States
- Christiana Care Health System-Christiana Hospital Newark, Delaware, United States
- Baptist MD Anderson Cancer Center Jacksonville, Florida, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
Completed
Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors
NCT00859937
- Conditions
- Head and Neck Neoplasms, Malignant Salivary Gland Neoplasm, Mouth Diseases, +9 more
- Locations
-
- Tower Cancer Research Foundation Beverly Hills, California, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- Mercy UC Davis Cancer Center Merced, California, United States
NCT01256385
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +49 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora, Colorado, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Northwestern University Chicago, Illinois, United States
NCT00458978
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +36 more
- Locations
-
- Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
Active, Not Recruiting
Testing the Anti-cancer Drug Darolutamide in Patients With Testosterone-Driven Salivary Gland Cancers
NCT05669664
- Conditions
- Head and Neck Neoplasms, Locally Advanced Salivary Gland Carcinoma, Metastatic Salivary Gland Carcinoma, +9 more
- Locations
-
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
- Los Angeles General Medical Center Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States